Acute Myeloid Leukemia Market: Rising Demand for CAGR Is Expected Grow the Revenue of the Market by 2019-2025: Clavis Pharma, Eisai, Genzyme Corporation
Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection.
View full press release